A challenging public health policy landscape under health secretary Robert F. Kennedy has vaccine makers rethinking ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...
Under the Trump administration, the government has rescinded research funding, changed vaccine recommendations, and refused ...
Platform-enabled vaccine design unlocks safer, more effective solutions with outer-membrane vesicles (OMVs) emerging as ...
THE VACCINE MAKER MODERNA decided this past week to tell the world about bad news it had received from the federal government ...
4d
CD Bioparticles Announces Advanced Engineering Platform for OMV-Based Bacterial Vaccine Development
CD Bioparticles launches comprehensive OMV-Based Bacterial Vaccines Development services for infectious disease and ...
Mani Foroohar, M.D., of Leerink Partners, says that the decision reflects “how sharp the departure has been between the prior ...
The U.S. Food and Drug Administration announced recently that it will not review Moderna’s mRNA flu vaccine, despite late-stage trials showing it was safe and effective. The rejection has many in and ...
Officials are going after metal-containing ingredients, including aluminum adjuvants. Here’s why vaccines need them ...
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results